Market Size of Global Digital Therapeutic Devices Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 7.58 Billion |
Market Size (2029) | USD 24.48 Billion |
CAGR (2024 - 2029) | 26.40 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Digital Therapeutic Devices Market Analysis
The Global Digital Therapeutic Devices Market size is estimated at USD 7.58 billion in 2024, and is expected to reach USD 24.48 billion by 2029, growing at a CAGR of 26.40% during the forecast period (2024-2029).
The outbreak of COVID-19 has also prompted healthcare professionals to seek alternatives to traditional systems and procedures. This leads to the rapid adoption of digital medical care across the industry from providers to consumers. As non-essential requirements are given low priority during the pandemic, patients turn to digital therapeutic solutions. In May 2020, a research study published titled "Digital physical therapy in the COVID-19 pandemic" stated that the worldwide COVID-19 pandemic forced the Brazilian health system to promptly adopt telehealth in different health care areas. Treatment efficacy and patient evaluation using digital practice were already investigated for some acute and chronic musculoskeletal conditions, cardiac conditions, neurological problems, post-surgical rehabilitation, pain management, pelvic floor conditions, and respiratory dysfunctions. Hence, increasing research studies would provide insight into the impact of COVID on the market. Thus, the market will grow in upcoming future.
According to the study 'The Longitudinal Ageing Study in India (LASI)' published in January 2021, approximately 75 million ages above 60 years of age suffer from some chronic disease. About 45 million have cardiovascular disease and hypertension and about 20 million suffer from diabetes. Thus, the high prevalence of chronic diseases in the country will boost the demand for cost-effective therapeutics such as digital therapeutic devices, thus driving the studied market. There has been a rise in the use of technology for therapeutics for medical conditions. Consumers in developed markets are increasingly aware of the advanced products for the treatment of medical conditions. In July 2019, according to the Organization for Economic Co-operation and Development, healthcare spending as a share of GDP has increased significantly in 2020, as the economic situation worsened and health spending increased in many OECD countries. Preliminary health spending for a group of 16 countries suggest that per capita health increased by around 4.9% on average in 2020. The preference is also, therefore, shifted toward the advanced services in the medical field, including the growing demand for innovations in therapeutic devices. Product apporval are another factor for the growth of the market. For instance, in December 2020, the United States Food and Drug Administration awarded a De Novo marketing authorization to San Francisco and London-based Mahana Therapeutics for a product called Parallel, which according to company materials is an 8-week cognitive behavioral therapy program for people with irritable bowel syndrome. Such approvals will increase the market growth.
The companies are also increasingly rising on venture investments in this domain, which drives this market. Factors, such as patient's data privacy concerns associated with digital therapeutic devices, hinder the growth of this market.
Digital Therapeutic Devices Industry Segmentation
According to the scope of the report, digital therapeutic devices are therapeutic interventions driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. They are different from digital medicines or smart pills, which combine a prescription medication with an ingestible sensor that is designed to communicate with a software application to track compliance. The digital therapeutic devices market is segmented by product (software and services and devices), application (preventive (pre-diabetes, obesity, smoking cessation, and others), treatment/care (cardiovascular diseases, central nervous system disease, diabetes, musculoskeletal diseases, respiratory diseases, and others)), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product Type | |
Software and Services | |
Devices |
By Application | |||||||
| |||||||
|
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Digital Therapeutic Devices Market Size Summary
The digital therapeutics market is experiencing significant growth, driven by the increasing adoption of technology-based medical solutions and the rising prevalence of chronic diseases. The COVID-19 pandemic has accelerated the shift towards digital health tools, as healthcare professionals and patients sought alternatives to traditional medical practices. This shift has been supported by research and studies highlighting the efficacy of digital therapeutics in managing various health conditions, from musculoskeletal and cardiac issues to post-surgical rehabilitation and pain management. The demand for cost-effective and innovative therapeutic devices is further fueled by the aging population and the high incidence of chronic diseases, such as diabetes and cardiovascular conditions, particularly in low- and middle-income countries. The market is also benefiting from regulatory approvals and strategic partnerships among key players, which are enhancing the availability and adoption of digital therapeutic solutions.
North America is poised to lead the digital therapeutics market, supported by early technology adoption, substantial investments, and favorable government initiatives aimed at increasing the availability of digital medical devices. The region's growth is further bolstered by acquisitions and collaborations among major companies, which are expanding their reach and capabilities in the digital health space. The competitive landscape is marked by the presence of numerous players, including Philips NV, Omada Health Inc., and Pear Therapeutics, who are actively engaging with healthcare systems, payers, and pharmaceutical companies to drive market expansion. As the demand for wireless and portable systems grows, along with a sophisticated reimbursement structure, the digital therapeutics market is expected to continue its upward trajectory, offering promising opportunities for innovation and growth in the coming years.
Global Digital Therapeutic Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Burden of Chronic Diseases
-
1.2.2 Rise in Technological Adavancements
-
1.2.3 Increasing Focus Toward Preventive Healthcare by Government and Rise in Venture Capital Investments
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Manufacturing and Installation
-
1.3.2 Data Privacy Concerns and Resistance from Traditional Healthcare Providers
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Software and Services
-
2.1.2 Devices
-
-
2.2 By Application
-
2.2.1 Preventive
-
2.2.1.1 Pre-diabetes
-
2.2.1.2 Obesity
-
2.2.1.3 Smoking Cessation
-
2.2.1.4 Others
-
-
2.2.2 Treatment/Care
-
2.2.2.1 Cardiovascular Diseases
-
2.2.2.2 Diabetes
-
2.2.2.3 Neurological Disorders
-
2.2.2.4 Respiratory Diseases
-
2.2.2.5 Others
-
-
-
2.3 By Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Digital Therapeutic Devices Market Size FAQs
How big is the Global Digital Therapeutic Devices Market?
The Global Digital Therapeutic Devices Market size is expected to reach USD 7.58 billion in 2024 and grow at a CAGR of 26.40% to reach USD 24.48 billion by 2029.
What is the current Global Digital Therapeutic Devices Market size?
In 2024, the Global Digital Therapeutic Devices Market size is expected to reach USD 7.58 billion.